1,232
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey

, MDORCID Icon, , MD, , MD & , PhD
Pages 269-277 | Received 10 Nov 2020, Accepted 26 May 2021, Published online: 19 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jamarie Geller, Nicolas Glynos, Andrew Lemmen, Rachel Pacilio, Daniel J. Kruger & Avinash Hosanagar. (2024) Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study. Journal of Psychoactive Drugs 0:0, pages 1-8.
Read now
Daniel J. Kruger, Nicolas G. Glynos, Christopher W. Fields, Moss Herberholz & Kevin F. Boehnke. (2023) An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically. Journal of Psychoactive Drugs 55:4, pages 420-424.
Read now
Nicolas G. Glynos, Christopher W. Fields, Julie Barron, Moss Herberholz, Daniel J. Kruger & Kevin F. Boehnke. (2023) Naturalistic Psychedelic Use: A World Apart from Clinical Care. Journal of Psychoactive Drugs 55:4, pages 379-388.
Read now

Articles from other publishers (13)

Yuan Yao, Dan Guo, Tang-Sheng Lu, Fang-Lin Liu, Shi-Hao Huang, Meng-Qi Diao, Su-Xia Li, Xiu-Jun Zhang, Thomas R Kosten, Jie Shi, Yan-Ping Bao, Lin Lu & Ying Han. (2024) Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research 335, pages 115886.
Crossref
Julia Ruixi Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola, Diana English & Kristopher Kaliebe. (2024) Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress. Frontiers in Psychiatry 15.
Crossref
Michelle St. Pierre, Lucas StandingYarissa HermanMark HadenZach Walsh. (2024) Patients' Experiences Discussing Psychedelics for Therapeutic Purposes with Physicians and Other Health Care Providers. Psychedelic Medicine.
Crossref
Syed Minhaj Rahman, Yousef Salem & Aamir Hussain. (2024) Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens. Dermatitis®.
Crossref
Elizabeth Sugiarto, Rebecca Leung & Jamie Yuen. (2024) Pharmacists’ perspectives on psilocybin in Canada. JAPhA Practice Innovations 1:2, pages 100003.
Crossref
Charlie Song-Smith, Edward Jacobs, James Rucker, Matthew Saint, James Cooke & Marco Schlosser. (2024) UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. BMJ Open 14:3, pages e083595.
Crossref
Brian S. Barnett, Miranda ArakelianDavid BeebeJared OntkoConnor RiegalWillie O. SiuJeremy Weleff & Harrison G. Pope. (2024) American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey. Psychedelic Medicine 2:1, pages 1-9.
Crossref
David B. Yaden, Andrea P. Berghella, Peter S. Hendricks, Mary E. Yaden, Michael Levine, Julia S. Rohde, Sandeep Nayak, Matthew W. Johnson & Albert Garcia-Romeu. (2024) IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models. Pharmacological Research 199, pages 106998.
Crossref
Amanda Kim & Joji Suzuki. (2023) Addiction specialists' attitudes toward psychedelics: A National Survey. The American Journal on Addictions 32:6, pages 606-609.
Crossref
Kevin F. Boehnke, Kasey Cox, Cody Weston, Moss Herberholz, Nicolas Glynos, Nicholas Kolbman, Christopher W. Fields, Julie Barron & Daniel J. Kruger. (2023) Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers. Frontiers in Psychiatry 14.
Crossref
Irene Li, Rodney Fong, Molly Hagen & Burton Tabaac. (2023) Medical student attitudes and perceptions of psychedelic-assisted therapies. Frontiers in Psychiatry 14.
Crossref
Elliot Marseille, Stefano Bertozzi & James G. Kahn. (2022) The economics of psychedelic-assisted therapies: A research agenda. Frontiers in Psychiatry 13.
Crossref
Brian S. Barnett & Jeremy Weleff. (2022) Psychedelics in the Treatment of Substance Use Disorders. Psychiatric Annals 52:9, pages 365-370.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.